Evaluation of a community pharmacy-based intervention for improving patient adherence to antihypertensives: A randomised controlled trial

BMC Health Services Research

Volumn 10, Issue , 2010, Pages

  Lau, Rosalind ^a   Stewart, Kay ^a   McNamara, Kevin P ^a,b   Jackson, Shane L ^c   Hughes, Jeffery D ^d   Peterson, Gregory M ^c   Bortoletto, Diana A ^a   McDowell, Jenny ^a   Bailey, Michael J ^a   Hsueh, Arthur ^e   George, Johnson ^a  

^a MONASH UNIVERSITY   (Australia)

^b DEAKIN UNIVERSITY   (Australia)

^c UNIVERSITY OF TASMANIA   (Australia)

^d CURTIN UNIVERSITY   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ARTICLE; AUSTRALIA; CLINICAL TRIAL; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVIDENCE BASED MEDICINE; FEMALE; HEALTH CARE QUALITY; HUMAN; HYPERTENSION; INFORMATION PROCESSING; MALE; METHODOLOGY; MULTICENTER STUDY; PARTICIPATORY RESEARCH; PATIENT COMPLIANCE; PHARMACY; RANDOMIZED CONTROLLED TRIAL;

ANTIHYPERTENSIVE AGENTS; AUSTRALIA; COMMUNITY-BASED PARTICIPATORY RESEARCH; DATA COLLECTION; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; HYPERTENSION; MALE; PATIENT COMPLIANCE; PHARMACIES; PHARMACY; PROGRAM EVALUATION; SOFTWARE;

EID: 77649227334     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-10-34     Document Type: Article

References (25)

1. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Collaborative Prospective Studies, Lancet 2002 360 1903 1913 10.1016/S0140-6736(02)11911-8 12493255
2. Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group, JAMA 2002 288 2981 2997 10.1001/jama.288.23.2981 12479763
3. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. LZS Hansson B Carruthers D Dahlöf SJ Elmfeldt J Ménard K Rahn H Wedel S Westerling, Lancet 1998 351 9118 1755 1762 10.1016/S0140-6736(98)04311-6 9635947 (Pubitemid 28269185)
4. Untreated hypertension among Australian adults: the 1999-2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). EM Briganti JE Shaw SJ Chadban PZ Zimmet TA Welborn JJ McNeil RC Atkins, Med J Aust 2003 179 3 135 139 12885281
5. Prevalence, detection and drug treatment of hypertension in a rural Australian population: the Greater Green Triangle Risk Factor Study 2004-2006. ED Janus SJ Bunker A Kilkkinen K Mc Namara B Philpot P Tideman R Tirimacco TK Laatikainen S Heistaro JA Dunbar, Intern Med J 2008 879 886 10.1111/j.1445-5994. 2007.01583.x 18284462
6. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. M Burnier, Am J Hypertens 2006 19 11 1190 1196 10.1016/j.amjhyper.2006.04.006 17070434
7. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. B Vrijens G Vincze P Kristanto J Urquhart M Burnier, BMJ 2008 336 7653 1114 1117 10.1136/bmj.39553. 670231.25 18480115
8. Persistence with treatment for hypertension in actual practice. JJ Caro M Salas JL Speckman G Raggio JD Jackson, CMAJ 1999 160 1 31 37 9934341
9. Persistence with hypertension treatment among community-dwelling BC seniors. SG Morgan L Yan, Can J Clin Pharmacol 2004 11 2 267 273 15596883
10. Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings. K Schroeder T Fahey S Ebrahim, Cochrane Database Syst Rev 2004 2 D004804 15106262
11. Effect of value-added utilities on prescription refill compliance and health care expenditures for hypertension. TL Skaer DA Sclar DJ Markowski JK Won, J Hum Hypertens 1993 7 5 515 518 8263895
12. Efficacy of a home blood pressure monitoring programme on therapeutic compliance in hypertension: the EAPACUM-HTA study. E Marquez-Contreras N Martell-Claros V Gil-Guillen M de la Figuera-Von Wichmann JJ Casado-Martinez JL Martin-de Pablos M Figueras J Galera A Serra, J Hypertens 2006 24 1 169 175 10.1097/01.hjh.0000198023.53859.a2 16331115
13. Interventions to enhance medication adherence. RB Haynes X Yao A Degani S Kripalani A Garg HP McDonald, Cochrane Database Syst Rev 2005 4 D000011 16235271
14. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JK Lee KA Grace AJ Taylor, JAMA 2006 296 21 2563 2571 10.1001/jama.296.21.joc60162 17101639
15. Pharmacy Cardiovascular Health Care Model. GM Peterson J Hughes K Stewart R Nation S Scott K Farris S Jackson K Fitzmaurice P Gee L Bereznicki, http://www.guild.org.au/research/project-display.asp?id=276 Accessed 12 September 2009.
16. Concurrent and predictive validity of a self-reported measure of medication adherence. DE Morisky LW Green DM Levine, Med Care 1986 24 1 67 74 10.1097/00005650-198601000-00007 3945130
17. Development and validation of the Beliefs and Behaviour Questionnaire (BBQ). J George A Mackinnon DC Kong K Stewart, Patient Educ Couns 2006 64 50 60 10.1016/j.pec.2005.11.010 16843634
18. MedsIndex: Medication compliance - The new frontier. http://www. fruityweb.com.au/pga/080520A Accessed 12 September 2009.
19. Pharmacy access/remoteness index of Australia (PhARIA) 2008-2009. http://www.gisca.adelaide.edu.au/projects/pharia-0809/PhARIA-info.html Accessed 12 September 2009
20. The Hawthorne Experiments: First Statistical Interpretation. RH Franke JD Kaul, Am Sociol Rev 1978 43 5 623 643 10.2307/2094540
21. The Hawthorne Effect: a randomised, controlled trial. R McCarney J Warner S Iliffe R Van Haselen M Griffin F P, BMC Med Res Methodol 2007 7 30 10.1186/1471-2288-1187-1130 17608932
22. Persistence with antihypertensive medication: Australia-wide experience, 2004-2006. LA Simons M Ortiz G Calcino, MJA 2008 188 4 224 227 18279129
23. The World Health organization MONICA project (Monitoring trends and determinants in cardiovascular disease): A major international collaboration. WHO MONICA PROJECT PRINCIPAL INVESTIGATORS, J Clin Epidemiol 1988 41 2 105 114 10.1016/0895-4356(88)90084-4 3335877
24. Quality assessment of data on awareness and treatment of high cholesterol in the WHO MONICA Project. http://www.ktl.fi/publications/monica/hich/hchdrug. htm Accessed 12 September 2009
25. Assessing utility where short measures are required: Development of the short assessment of quality of life-8 (AQoL-8) Instrument. G Hawthorne, Value In Health 2009 12 6 948 957 10.1111/j.1524-4733.2009.00526.x 19490558